Full text
Earnings transcript
Read the complete earnings call transcript.
FCRX
Crescent Capital BDC, Inc.
$25.17
0
(0%)
| Exchange: | NYSE |
| Market Cap: | 931.549M |
| Shares Outstanding: | 27.682M |
Delayed data
About The Company
| Sector: | Financial Services | |||||
| Industry: | Asset Management | |||||
| CEO: | Jason A. Breaux | |||||
| Full Time Employees: | ||||||
| Address: |
| |||||
| Website: | https://www.crescentbdc.com |
Crescent Capital BDC, Inc. functions as a business development company (BDC), focusing its efforts on both direct investments and fund-of-funds strategies. The firm primarily targets middle-market enterprises, allocating capital across a spectrum of debt and equity instruments. Its investment mandates encompass various transaction types, including Private Investments in Public Equities (PIPEs), financing for expansion, acquisitions, market or product diversification, recapitalizations, support for mature businesses, and change-of-control scenarios. These investments are made in both sponsored and independent entities. Conversely, the BDC explicitly avoids investments in nascent ventures, operationally troubled enterprises, or businesses predicated on uncertain or speculative models. While debt securities form the cornerstone of its portfolio, particularly unsecured subordinated or mezzanine debt and second-lien secured debt, such instruments often feature an embedded equity element. This can take the form of warrants, preferred shares, options for minority stakes, or comparable equity-linked securities. The investment scope also extends to high-yield fixed income, private equity holdings, publicly traded securities, and positions in non-U.S. entities. Key sectors of interest include outsourced business solutions, healthcare, financial services, retail, media, and consumer discretionary industries. Beyond its primary focus, the BDC is prepared to make direct equity investments, which can also be channeled through other funds. It further selectively participates in syndicated first-lien secured loans, encompassing unitranche financing. Transaction sizes typically range from $10 million to $25 million. The target companies generally exhibit annual revenues between $25 million and $500 million, coupled with annual EBITDA figures spanning $5 million to $25 million. The firm’s preference is to assume the role of a lead or exclusive investor in its dealings.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 184,134 | 197,363 | 156,186 |
| Gross Profit | 184,134 | 197,363 | 121,852 |
| EBITDA | 0 | 0 | 93,629 |
| Operating Income | 142,590 | 153,349 | 118,933 |
| Net Income | 83,837 | 73,649 | 34,509 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 1,627,379 | 1,656,274 | 1,622,135 |
| Total Liabilities | 884,785 | 915,637 | 916,097 |
| Total Stockholders Equity | 742,594 | 740,637 | 706,038 |
| Total Debt | 844,783 | 875,837 | 873,761 |
| Cash and Cash Equivalents | 7,780 | 10,130 | 31,497 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 92,298 | 58,907 | 46,768 |
| Capital Expenditure | 0 | 0 | 0 |
| Free Cash Flow | 92,298 | 58,907 | 46,768 |
| Net Income | 83,837 | 73,649 | 34,509 |
| Net Change in Cash | 7,403 | 14,952 | -7,925 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2028 | Full Access | Full Access | Full Access | Full Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 138,551.800 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (High) | 147,802.843 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (Avg) | 142,391.400 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Low) | 16,611.561 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (High) | 17,720.707 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Avg) | 17,071.907 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Low) | 57,550.552 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (High) | 62,587.836 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Avg) | 59,641.332 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Low) | 25,533.340 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (High) | 27,238.190 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Avg) | 26,240.929 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Avg) | 1.610 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (High) | 1.690 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Low) | 1.550 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated Revenue) | 1 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated EPS) | 1 | Full Access | Full Access | Full Access | Full Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates FCRX intrinsic value between $23.39 – $25.40 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about FCRX valuation
Is Crescent Capital BDC, Inc. (FCRX) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for Crescent Capital BDC, Inc. (FCRX) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is FCRX a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether FCRX trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is FCRX’s P/E ratio?
You can see FCRX’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for FCRX?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is FCRX a good long-term investment?
Whether FCRX fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
FCRX
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
0
Trading Metrics:
| Open: | 25.17 | Previous Close: | 25.17 | |
| Day Low: | 25.15 | Day High: | 25.17 | |
| Year Low: | 24.5 | Year High: | 25.24 | |
| Price Avg 50: | 25.04 | Price Avg 200: | 25 | |
| Volume: | 1222 | Average Volume: | 2272 |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's free